170.00 -0.27 (-0.16%)
After hours: 7:59PM EDT
|Bid||170.72 x 900|
|Ask||170.34 x 1000|
|Day's range||169.24 - 171.53|
|52-week range||133.65 - 173.65|
|Beta (5Y monthly)||0.71|
|PE ratio (TTM)||30.08|
|Earnings date||21 Jul 2021|
|Forward dividend & yield||4.24 (2.49%)|
|Ex-dividend date||24 May 2021|
|1y target est||186.80|
Dr. Sejal Hathi, Physician & Clinical Fellow at Massachusetts General Hospital & host of “Civic Rx” podcast, joined Yahoo Finance to discuss the lastest on covid-19.
Leading the call will be Dr. Helen Torley, Halozyme's President and Chief Executive Officer, who will provide an update on our business; and Elaine Sun, our Chief Financial Officer, who will review our financial results for the first quarter. Thank you, Al. I'm pleased to report that our first quarter results provided a strong start to 2021 for Halozyme.
Style Box ETF report for IWX